SimBioSys Secures FDA Clearance for TumorSight® Risk, Introducing the World’s First AI-Powered, MRI-Derived Breast Cancer Recurrence Risk Assessment
Novel software transforms routinely collected MRI, pathology and clinical data into personalized five- and ten-year recurrence risk insight for women...
Atlas-HRT.com Launches Online TRT and Men’s Health Platform in Florida, as Men Over 40 Look for Clear Answers on Testosterone Therapy